Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Radiation Treatment for Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02019576
What this trial is testing

Stereotactic Radiotherapy for Metastatic Kidney Cancer Being Treated With Sunitinib

Who this might be right for
Clear Cell Metastatic Renal Cell Carcinoma
Sunnybrook Health Sciences Centre 38
Testing effectiveness (Phase 2)Study completedNCT00226590
What this trial is testing

Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC

Who this might be right for
Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 39
Not applicableEnded earlyNCT03402737
What this trial is testing

SBRT + Immunomodulating Systemic Therapy for Inoperable, Recurrent H&N

Who this might be right for
Head and Neck Neoplasm
University Hospital, Ghent 6
Not applicableUnknownNCT00714077
What this trial is testing

Adjuvant Treatment of Concurrent RT and CAPOX or Capecitabine Alone for Stage II and III Rectal Cancer

Who this might be right for
Rectal Neoplasms
Chinese Academy of Medical Sciences 570
Not applicableStudy completedNCT00612963
What this trial is testing

Novel Rinse to Treat in Oral Candidiasis in Cancer Patients

Who this might be right for
Candidiasis, OralThrushCandidiasis
Biomedical Development Corporation 23
Testing effectiveness (Phase 2)UnknownNCT02031328
What this trial is testing

Two StereoTactic Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
Sunnybrook Health Sciences Centre 30
Testing effectiveness (Phase 2)Ended earlyNCT04527900
What this trial is testing

The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach

Who this might be right for
Endometrial Cancer
University of Maryland, Baltimore 2
Early research (Phase 1)Study completedNCT00003200
What this trial is testing

Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT03224000
What this trial is testing

Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer

Who this might be right for
Malignant Neoplasms of Lip Oral Cavity and PharynxOropharyngeal Cancer
M.D. Anderson Cancer Center 90
Large-scale testing (Phase 3)Study completedNCT00354744
What this trial is testing

High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma

Who this might be right for
Sarcoma
Children's Oncology Group 109
Not applicableNot Yet RecruitingNCT06430411
What this trial is testing

Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study

Who this might be right for
Prostate Cancer MetastaticProstate Cancer Metastatic to BoneProstate Cancer+3 more
Medical University of Vienna 500
Testing effectiveness (Phase 2)Study completedNCT02723331
What this trial is testing

Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates

Who this might be right for
Pancreatic CancerPancreatic AdenocarcinomaPancreas Ductal Adenocarcinoma
Academic Thoracic Oncology Medical Investigators Consortium 48
Not applicableActive Not RecruitingNCT01342367
What this trial is testing

Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Chicago 74
Not applicableEnded earlyNCT00503867
What this trial is testing

SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma

Who this might be right for
Carcinoma, HepatocellularHepatoma
Sirtex Medical 10
Testing effectiveness (Phase 2)Study completedNCT02289456
What this trial is testing

Phase II Safety and Tolerability Trial With Nab-Paclitaxel Plus Carboplatin Followed by Nab-Paclitaxel for First Line Treatment of NSCLC Subjects With ECOG PS 2

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Celgene 40
Not applicableNot Yet RecruitingNCT05614700
What this trial is testing

Prostate Reirradiation Toxicity Outcomes Feasibility Study

Who this might be right for
Prostate CancerRadiotherapy Side Effect
University of Leeds 60
Large-scale testing (Phase 3)Study completedNCT00971399
What this trial is testing

Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting

Who this might be right for
Radiotherapy Induced Nausea and Vomiting
Seoul National University Hospital 172
Testing effectiveness (Phase 2)Looking for participantsNCT02734537
What this trial is testing

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Who this might be right for
Head and Neck Squamous Cell CarcinomaHypopharyngeal Squamous Cell CarcinomaLaryngeal Squamous Cell Carcinoma+13 more
ECOG-ACRIN Cancer Research Group 189
Not applicableNot Yet RecruitingNCT07769372
What this trial is testing

Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Prostate Cancer

Who this might be right for
Stage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8Stage IIIA Prostate Cancer AJCC v8+2 more
City of Hope Medical Center 20
Not applicableUnknownNCT03381430
What this trial is testing

Gefitinib Combine Radiotherapy as Therapy for Patients With NSCLC Harbouring Sensitive Mutations of EGFR

Who this might be right for
Lung Cancer
Qilu Pharmaceutical Co., Ltd. 50
Next Page